The Latest
-
Alamy
Boston Scientific inks $88M Elutia deal to challenge Medtronic
BTIG analysts estimate that Elutia’s Elupro and Medtronic’s TYRX are competing for a $600 million opportunity in the U.S. cardiac rhythm management sector.
Updated Sept. 11, 2025 -
Patrik Stollarz / Staff via Getty Images
Philips under investigation by Paris Prosecutor’s Office over recalled respiratory devices
The prosecutor’s office opened an investigation in June, with charges including aggravated fraud and failure to report incidents that pose serious health risks.
-
Andrew Harnik/Getty via Getty Images
Supreme Court to hear Trump’s tariff legality case in November
The high court granted an expedited review of an appellate court finding that the president's sweeping tariffs were illegal.
-
Permission granted by Pulse Biosciences
Pulse wins IDE approval; Galvanize pulls in $100M
Pulse Biosciences will study PFA in cardiac surgery. Meanwhile, Galvanize Therapeutics also named a new CEO, and PFA pioneer Steven Mickelsen has launched another company.
-
Sarah Silbiger via Getty Images
Microbot receives 510(k) clearance for endovascular robot
The company will now complete final commercial activities in preparation for targeting the 2.5 million peripheral vascular procedures performed in the U.S. each year.
-
Courtesy of Ronovo Surgical
Ronovo Surgical raises $67M, led by J&J venture arm
Ronovo, a Chinese surgical robotics company, will also team with a J&J subsidiary in Shanghai to sell Ronovo’s soft tissue platform and complementary J&J technologies.
-
Permission granted by Senseonics
Senseonics inks deal to bring CGM commercialization back in-house
BTIG analysts said Senseonics is doubling down on its belief an inflection point in patient demand is imminent, but the company will need a large sales force to win market share.
-
Rebecca Pifer/MedTech Dive
Judge allows Epic antitrust suit to move forward
A judge dismissed several claims brought by startup Particle Health against the EHR giant, but allowed some federal allegations to continue in court.
-
Courtesy of Medtronic
Medtronic trial of Hugo robot in hernia repair hits primary endpoints
The company reported a 100% surgical success rate, beating the pre-specified 85% performance goal to meet the trial’s primary effectiveness endpoint.
-
Alamy
Dexcom to lay off about 350 people
The diabetes technology company said the cuts are part of broader changes to its structure, including eliminating operations roles in San Diego and shifting those positions to Arizona.
-
Courtesy of Medtronic
Renal denervation gets strong backing from cardiologists ahead of Medicare coverage decision
Doctors told the Centers for Medicare and Medicaid Services that more patients need access to the procedure, with one calling it the start of a new era in hypertension management.
-
Permission granted by Ketryx
AI firm Ketryx raises $39M, adds former Medtronic CEO as investor
The company, which helps medtech companies with AI compliance, has raised more than $55 million to date.
-
Andrew Harnik via Getty Images
At Senate hearing, lawmakers express dissatisfaction with RFK Jr.’s vaccine moves
Robert F. Kennedy Jr. faced criticism Thursday even from Republican lawmakers over changes to federal vaccine policy as well as a leadership crisis at the CDC.
-
Courtesy of Kardium
Kardium receives FDA OK for pulsed field ablation system
The company raised $250 million in July to expand its manufacturing capabilities and establish multiple teams to support the launch.
-
Kayla Bartkowsk via Getty Images
Over 1,000 HHS employees call for RFK Jr. to step down
The letter cites turmoil at the CDC, which is reeling from the firing of Director Susan Monarez and the departure of at least four high-level leaders last week.
-
Permission granted by Medtronic
Medtronic advances Abbott partnership with FDA nod
The company received FDA authorization to pair its 780G insulin pump with a glucose sensor made by Abbott, and to use the device for Type 2 diabetes.
-
Courtesy of Johnson & Johnson
3 medtech takeaways from ESC 2025
Pulsed field ablation and transcatheter aortic valve implants were in focus at the European Society of Cardiology Congress in Madrid.
-
Courtesy of Edwards Lifesciences
Edwards, Medtronic and Abbott stand to benefit from new TAVR guidelines in Europe
Analysts said the companies should benefit “as the therapy algorithm is further streamlined and additional patients are encouraged to receive TAVR.”
-
Martin Barraud via Getty Images
AI devices with no clinical validation tied to more recalls, study finds
Public companies, which accounted for about half of AI-enabled devices on the market, had a higher rate of recalls and a lower rate of clinical evidence, according to a JAMA study.
-
Alamy
Medtech VC funding on track to hit highest value since 2021: PitchBook
“Larger rounds increasingly favor top-tier companies and AI-native startups, leaving other startups fighting for a smaller pool of capital,” the firm said.
-
Chip Somodevilla via Getty Images
Appellate court rules Trump’s global tariffs illegal, but delays action
The court intends to strike down the tariffs by mid-October, pending a Supreme Court review of the ruling.
-
Sarah Silbiger via Getty Images
Deep Dive4 medtech topics to watch for the rest of 2025
From M&A to MDUFA and the developing market in renal denervation, MedTech Dive covers the key issues to watch in the final months of the year.
